125 - Mind Blown: Challenging HIV Clinical Cases

Friday, October 18, 2024

10:30 AM – 11:45 AM US PT

Location: Petree D

All relevant financial relationships have been mitigated.

CME Credits: Maximum of 1.25 hours of AMA PRA Category 1 Credit™
MOC Credits: Maximum of 1.25 hours of MOC Credit
CNE Credits: Maximum of 1.25 hours of ANCC Credit
ACPE Credits: ACPE 1.25 knowledge-based contact hours of pharmacy CE
ACPE Number: JA0007082-9999-24-002-L01-P
PACE Credits: Maximum of 1 of PACE contact hours
CE Broker: Maximum of 1 CE broker credit hours

Interactive Moderator(s)

Joseph Garland, MD (he/him/his)

Medical Director
Immunology Center, The Miriam Hospital, RI, United States

Slides
April Pettit, MD, MPH (she/her/hers)

Associate Professor of Medicine
Department of Medicine, Division of Infectious Diseases
Vanderbilt University Medical Center
Nashville, TN, United States

Moderator(s)

Aadia Rana, MD (she/her/hers)

Professor of Medicine
University of Alabama-Birmingham Heersink School of Medicine
Birmingham, AL, United States

Panelist(s)

Becky Reece, MD (she/her/hers)

Associate Professor
Medicine/Infectious Diseases
West Virginia University
Morgantown, WV, United States
Ofole Mgbako, MD MS (he/him/his)

Assistant Professor of Medicine and Population Health; Section Chief of Infectious Diseases, NYC Health+Hospitals/Bellevue
NYU Grossman School of Medicine
Brooklyn, New York, United States
Rachel Presti, MD, PhD (she/her/hers)

Professor
Internal Medicine
Washington University
Saint Louis, MO, United States
Carina Marquez, MD, MPH

Associate Professor
Division of HIV, ID, Global Medicine, University of California San Francisco, Zuckerberg San Francisco General Hospital
San Francisco, CA, United States

Disclosure(s):

Joseph Garland: No financial relationships to disclose

April Pettit, MD, MPH: No financial relationships to disclose

Ofole Mgbako, MD MS: Gilead: Advisor/Consultant

Rachel M. Presti, MD, PhD: No financial relationships to disclose

Carina Marquez, MD, MPH: No financial relationships to disclose

Learning Objectives:

At the conclusion of this session, participants will be able to:

describe the benefits of long-acting antiretroviral prevention and treatment options;
identify key considerations to management of hiv resistance associated mutations;
explain approaches to managing patients with hiv and substance use disorders;
identify novel strategies for care engagement and retention.